HDFC Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1568 Cr | ₹8161 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.14 | 1.82 |
Manager | Dhruv Muchhal | Sailesh Raj Bhan |
ISIN Code | INF179KC1HL7 | INF204K01968 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 6.22% | 6.32% |
6 Month | 0.86% | 0.19% |
1 Year | 28.21% | 14.6% |
3 Year | - | 24.76% |
5 Year | - | 22.02% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 3.07% | 4.34% |
1 Year | 9.65% | 5.61% |
3 Year | - | 23.65% |
5 Year | - | 19.48% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 34.78% | 17.67% |
3 Year | - | 20.32% |
5 Year | - | 20.52% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | - | 15.623% |
Sharp | - | 0.707% |
Beta | - | 0.908% |
Alpha | - | 0.486% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Dhruv Muchhal | Sailesh Raj Bhan |
Total AUM | ₹520687 Cr | ₹96086 Cr |
Funds Managed | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 4.17 | 1.36 |
Small Cap | 34.62 | 27.14 |
Large Cap | 35.28 | 38.72 |
Mid Cap | 25.93 | 32.78 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 2.47 | 1.36 |
Basic Materials | 2.04 | - |
Healthcare | 95.49 | 98.64 |
Top Comparisons
BANDHAN Low Duration Fund - Regular Plan - Growth
3Y Returns7.11%
Tata Treasury Advantage Fund - Regular Plan - Growth Option
3Y Returns7.06%
Aditya Birla Sun Life Asset Allocator FoF- Regular Plan - Growth Option
3Y Returns17.72%
Kotak Multi Asset Allocator Fund of Fund - Dynamic - Growth
3Y Returns21.6%
Tata Money Market Fund-Regular Plan - Growth Option
3Y Returns7.44%
Axis Money Market Fund - Regular Plan - Growth Option
3Y Returns7.43%
HDFC Hybrid Equity Fund - Growth Plan
3Y Returns16.25%
Aditya Birla Sun Life Equity Hybrid 95 Fund - Regular Plan-Growth
3Y Returns15.57%